Helen Petousis-Harris | Academic Influence

Helen Petousis-Harris's AcademicInfluence.com Rankings

Helen Petousis-Harris

Philosophy

#12586

World Rank

#17517

Historical Rank

Logic

#9483

World Rank

#12029

Historical Rank

philosophy Degrees

Helen Petousis-Harris

Biology

#15764

World Rank

#19818

Historical Rank

Immunology

#1094

World Rank

#1123

Historical Rank

biology Degrees

Download Badge

Philosophy
Biology

Helen Petousis-Harris's Degrees

PhD Immunology University of Auckland
Bachelors Microbiology University of Auckland

Why Is Helen Petousis-Harris Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Helen Aspasia Petousis-Harris is a New Zealand vaccinologist and associate professor in the Department of General Practice and Primary Health Care at the University of Auckland. She has been involved in research related to vaccination in New Zealand since 1998, with her main areas of focus being vaccine safety and effectiveness. Petousis-Harris has had a variety of lead roles in New Zealand and international organisations that focus on vaccination and is a regular media spokesperson in this field, especially during the COVID-19 pandemic.

(See a Problem?)

Helen Petousis-Harris's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Effectiveness of a group B outer membrane vesicle meningococcal vaccine against gonorrhoea in New Zealand: a retrospective case-control study (2017) (231)
Family physician perspectives on barriers to childhood immunisation. (2004) (64)
Recruitment of practices in primary care research: the long and the short of it. (2009) (58)
Infant outcomes after exposure to Tdap vaccine in pregnancy: an observational study (2016) (57)
Vaccine injection technique and reactogenicity--evidence for practice. (2008) (56)
Family practice nurse views on barriers to immunising children. (2005) (53)
Factors associated with immunisation coverage and timeliness in New Zealand. (2010) (47)
Pertussis Immunisation in Pregnancy Safety (PIPS) Study: A retrospective cohort study of safety outcomes in pregnant women vaccinated with Tdap vaccine. (2018) (46)
Impact of meningococcal group B OMV vaccines, beyond their brief (2018) (43)
Safety of Tdap vaccine in pregnant women: an observational study (2016) (39)
Effectiveness of a Group B Outer Membrane Vesicle Meningococcal Vaccine in Preventing Hospitalization from Gonorrhea in New Zealand: A Retrospective Cohort Study (2018) (35)
Gonococcal vaccines: Public health value and preferred product characteristics; report of a WHO global stakeholder consultation, January 2019 (2020) (35)
Immunization in the Print Media—Perspectives Presented by the Press (2007) (31)
Barriers to childhood immunisation among New Zealand mothers (2002) (29)
Seize the moments: missed opportunities to immunize at the family practice level. (2009) (29)
Assessing the Safety of COVID-19 Vaccines: A Primer (2020) (25)
Exploitation of Neisseria meningitidis Group B OMV Vaccines Against N. gonorrhoeae to Inform the Development and Deployment of Effective Gonorrhea Vaccines (2019) (23)
Febrile events including convulsions following the administration of four brands of 2010 and 2011 inactivated seasonal influenza vaccine in NZ infants and children: the importance of routine active safety surveillance. (2012) (22)
MeNZB vaccine and epidemic control: when do you stop vaccinating? (2008) (22)
Global landscape analysis of no-fault compensation programmes for vaccine injuries: A review and survey of implementing countries (2020) (21)
Determining immunisation coverage rates in primary health care practices: A simple goal but a complex task (2008) (21)
Human papillomavirus vaccination in Auckland: reducing ethnic and socioeconomic inequities. (2012) (20)
Primary care practice and health professional determinants of immunisation coverage (2011) (19)
Measuring disparities in immunisation coverage among children in New Zealand. (2012) (19)
Age-specific effectiveness following each dose of acellular pertussis vaccine among infants and children in New Zealand. (2017) (19)
Inhaled modified angiotensin converting enzyme 2 (ACE2) as a decoy to mitigate SARS-CoV-2 infection. (2020) (19)
What contributes to delays? The primary care determinants of immunisation timeliness in New Zealand. (2012) (18)
The use and misuse of media headlines: lessons from the MeNZB immunisation campaign. (2009) (15)
Follow-up of MMR Vaccination Status in Children Referred to a Pediatric Immunization Clinic on Account of Egg Allergy (2005) (15)
Fever following administration of two inactivated influenza vaccines--a survey of parents of New Zealand infants and children 5 years of age and under. (2011) (15)
Immunization champions: Characteristics of general practitioners associated with better immunization delivery (2009) (14)
Pneumococcal Conjugate Vaccines Turning the Tide on Inequity: A Retrospective Cohort Study of New Zealand Children Born 2006–2015 (2018) (14)
An investigation of three injections techniques in reducing local injection pain with a human papillomavirus vaccine: a randomized trial. (2013) (13)
The cost of immunising at the general practice level. (2009) (12)
Proposed HPV vaccination syndrome is unsubstantiated (2016) (10)
Factors associated with reported pain on injection and reactogenicity to an OMV meningococcal B vaccine in children and adolescents (2015) (10)
Nurses make a difference in immunisation service delivery (2011) (10)
A Qualitative Study of Views and Experiences of Women and Health Care Professionals about Free Maternal Vaccinations Administered at Community Pharmacies (2020) (10)
A Retrospective Cohort Study of Safety Outcomes in New Zealand Infants Exposed to Tdap Vaccine in Utero (2019) (9)
Pneumococcal disease in New Zealand and prevailing inequalities, the tip of the lower respiratory infection iceberg. (2013) (9)
Early connections: effectiveness of a pre-call intervention to improve immunisation coverage and timeliness. (2012) (9)
Comparison of general practitioner and practice nurse perceived barriers to immunisation uptake (2005) (8)
Parent views on school based immunisation: A survey of parents of year 1 and 6 children in three diverse Auckland schools (2004) (8)
Influences on Pregnant Women’s and Health Care Professionals’ Behaviour Regarding Maternal Vaccinations: A Qualitative Interview Study (2022) (7)
Methodological frontiers in vaccine safety: qualifying available evidence for rare events, use of distributed data networks to monitor vaccine safety issues, and monitoring the safety of pregnancy interventions (2021) (6)
EFFECTIVENESS OF A GROUP B OMV MENINGOCOCCAL VACCINE ON GONORRHOEA IN NEW ZEALAND - A CASE CONTROL STUDY (2016) (6)
Increasing Uptake of Maternal Pertussis Vaccinations through Funded Administration in Community Pharmacies (2022) (5)
The New Zealand national immunisation hotline--what are callers seeking? (2005) (5)
Saturated fat has been unfairly demonised: yes. (2011) (4)
Immunisation education in the antenatal period (2004) (4)
Likelihood-based estimation and prediction for a measles outbreak in Samoa (2021) (3)
Correction to: Assessing the Safety of COVID-19 Vaccines: A Primer (2021) (3)
Impact of rotavirus vaccine on paediatric rotavirus hospitalisation and intussusception in New Zealand: A retrospective cohort study. (2019) (3)
Progress Toward a Global Vaccine Data Network. (2020) (2)
Comparison of vaccination coverage of four childhood vaccines in New Zealand and New York State (2018) (2)
Hepatitis B vaccination and diabetes. (1999) (2)
Examining immunisation in New Zealand (2009) (2)
A survey of parents of year 1 and 6 in three diverse Auckland schools (2004) (1)
2012 Antigen Review for the New Zealand National Immunisation schedule : Hepatitis B (2013) (1)
Criticism of the decision not to fund the HPV vaccine for pre-adolescent females in New Zealand, and response. (2007) (1)
An Observational Study to Assess the Effectiveness of 4CMenB against Meningococcal Disease and Carriage and Gonorrhea in Adolescents in the Northern Territory, Australia—Study Protocol (2022) (1)
Needle angle when giving i.m. vaccinations. (2002) (1)
2012 Antigen Review for the New Zealand National Immunisation Schedule: Diphtheria (2014) (1)
Mapping the maternal vaccination journey and influencing factors for Māori women in Aotearoa New Zealand: a qualitative study. (2022) (1)
2012 Antigen Review for the New Zealand National Immunisation Schedule: Human papillomavirus (2014) (1)
Impact of antivaccination campaigns on health worldwide: lessons for Australia and the global community (2020) (1)
Factors associated with vaccine reactogenicity in school aged children and young adults following administration of two protein-based vaccines (2011) (1)
Reply to “Comment on Effectiveness of a Group B Outer Membrane Vesicle Meningococcal Vaccine in Preventing Hospitalization from Gonorrhea in New Zealand: A Retrospective Cohort Study, Vaccines, 2019, 1, 5; doi:10.3390/vaccines7010005” (2019) (1)
Pertussis Vaccination Failure in the New Zealand Pediatric Population: Study Protocol (2019) (0)
Breakthrough pertussis in New Zealand infants and young children (2017) (0)
Pitfalls of the healthy vaccinee effect – Authors' reply (2018) (0)
2012 Antigen Review for the New Zealand National Immunisation Schedule: Tuberculosis (2014) (0)
The Anatomy of Immunity (2015) (0)
Prevention of anal HPV infection and anal cancer among gay and bisexual men in New Zealand (2014) (0)
2012 Antigen Review for the New Zealand National Immunisation Schedule: Influenza (2013) (0)
Likelihood-based estimation and prediction for misspecified epidemic models: an application to measles in Samoa (2021) (0)
2012 Antigen Review for the New Zealand National Immunisation Schedule: Measles, mumps and rubella (2014) (0)
2012 Antigen review for the New Zealand National Immunisation Schedule: Rotavirus (2014) (0)
Chapter 28. HPV Vaccines (2017) (0)
Inequities in pneumococcal disease following introduction of pneumococcal conjugate vaccine in NZ (2017) (0)
Reduction in sociodemographic disparities for Otitis Media hospitalisation rates in young children following introduction of pneumococcal conjugate vaccine in New Zealand, Gold Coast, 5th June 2017 (2017) (0)
2012 Antigen Review: Tetanus (2013) (0)
The MeNZB™ story, a new chapter (2017) (0)
Myths Surrounding Vaccines (2015) (0)
Cherry picked case reports are not scientific evidence in the face of large clinical and epidemiological studies (2016) (0)
Pertussis Immunisation in Pregnancy Safety (PIPS) Study: A Retrospective Cohort Study of Safety Outcomes in Infants Exposed to Tdap Vaccine in Utero (2019) (0)
Gardasil vaccination for high risk men: Early policy and research responses (2014) (0)
Author reply to VA-MENGOC-BC cross-protection (2018HV0022) (2018) (0)
Intravenous vitamin C. (2009) (0)
2012 Antigen Review for the New Zealand National Immunisation Schedule: Haemophilus influenza type b (2014) (0)
Vaccine hope against a sexually transmitted disease: the answer to the burgeoning rise in a superbug (2018) (0)
2012 Antigen Review for the New Zealand National Immunisation Schedule: Meningococcal B and C (2014) (0)
2012 Antigen Review: Varicella-zoster virus (chicken pox and shingles) (2014) (0)
2012 Antigen Review for the New Zealand National Immunisation Schedule: Pneumococcal (2014) (0)
Multi‐decade national cohort identifies adverse pregnancy and birth outcomes associated with acute respiratory illness hospitalisations during the influenza season (2022) (0)
Recommendation to Take a Holistic View of the Dynamic Pathogenic Pneumococcal Environment (2022) (0)
Antigen Literature Review for the New Zealand National Immunisation Schedule, 2016: Human papillomavirus (2016) (0)
2012 Antigen Review: Pertussis (2013) (0)

This paper list is powered by the following services:

Other Resources About Helen Petousis-Harris

en.wikipedia.org

What Schools Are Affiliated With Helen Petousis-Harris?

Helen Petousis-Harris is affiliated with the following schools:

University of Auckland